Skip to content

Anakinra for the Treatment of Severe Still's Disease Complicated With Macrophage Activation Syndrome

Oct 2026 · International Journal of Rheumatic Diseases · Vol 29 · 0 citations · 19 references
Medicine

Abstract

To investigate the efficacy and safety of add‐on anakinra for severe Still's disease complicated by macrophage activation syndrome (MAS) in a real‐world setting.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.